The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Uses and Use Restrictions
Funds are used for location and visitation of firms involved in the manufacture, distribution and transportation of animal feed, and operations feeding ruminant animals in their jurisdiction, to verify compliance with the ruminant feed ban.
Visitations could include annual inspections of renderers, protein blenders and feed mills that manufacture animal feeds and feed ingredients utilizing materials prohibited under the ruminant feed ban that are not covered under existing FDA contracts and other agreements.
Funds can be used for inspections of salvagers of food and feed, and transporters of animal feed and feed ingredients, supplies, training, laboratory equipment for feed sample testing, and as a supplement to the annual State program appropriations.
Funds may not be used to replace annual State program funds for these purposes.
Specific funding restrictions are as noted in the Funding Opportunity Announcement (FOA) and the Notice of Grant Award.
This cooperative agreement grant program is only available to State and Tribal Feed/BSE regulatory programs.
The general public, State and Tribal Feed/BSE regulatory programs.
Applications must present a project plan and furnish evidence that facilities, personnel and equipment are appropriate to carry out the project specific objectives as stated in the Funding Opportunity Announcement (FOA) as published in the Federal Register or NIH Guide. These awards are subject to Executive Order 12372, as it applies. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication coordination is required.
Environmental impact information is not required for this program.
This program is eligible for coverage under E.O.
12372, 'Intergovernmental Review of Federal Programs.' An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. The application forms referenced in the Funding Opportunity Announcement (FOA) as required by 45 CFR 72 must be used for this program. The FOA may be published in the NIH Guide or Federal Register. All applications submitted for new, competing continuations or competing supplemental grants must complete the required applications forms through Grants.gov at http://www.grants.gov.
All accepted applications receive a programmatic and objective review for technical merit and responsiveness to the Funding Opportunity funding criteria. All approved, recommended and scored applications compete for available funds on the basis of score, scientific/technical merit as well as programmatic relevance. Geographic distribution will be a consideration in the award selection process.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Public Health Security and Bioterrorism Preparedness and Response Act of 2002, Public Law 107-188.
Range of Approval/Disapproval Time
From 90 to 120 days.
From 15 to 30 days.
Renewals are available if allowed in the most recently published Funding Opportunity Announcement.
Formula and Matching Requirements
Statutory formulas are not applicable to this program. Matching requirements are not applicable to this program. MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance
The length of support will depend on the nature of the projects, program relevance and the availability of funds. For those projects with an expected duration of more than 1 year, future recommended support for up to 5 years will depend on (1) performance during the preceding year and (2) availability of Federal funds. See the following for information on how assistance is awarded/released: Notice of Award will be provided electronically or in hard copy.
Post Assistance Requirements
Program Reports are required as noted in the FOA and the Terms and Conditions of Award.
Cash reports are not applicable.
Progress Reports are required as stated in the FOA and the Terms and Conditions of Award.
Expenditure Reports are required as stated in the FOA and the Terms and Conditions of Award.
Performance Monitoring is required as stated in the FOA and the Terms and Conditions of Award.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Awarded grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Progress reports, financial and programmatic records, supporting documents, statistical records and all other records that are required by the terms and conditions of the grant or may be considered pertinent to a grant expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the required final financial reports for the project period. See 45 CFR 74.53 and 92.42 for exceptions and qualification to the 3 year retention requirement. See 45 CFR 74.48 and 92.36 for record retention and access requirements for contracts under grants.
(Cooperative Agreements) FY 16 $0; FY 17 est $0; and FY 18 est $0
Range and Average of Financial Assistance
No Data Available.
Regulations, Guidelines, and Literature
42 CFR Part 52-Grants for Research Projects; 45 CFR Part 74 - Uniform Administrative Requirements for Awards and Subawards to Institutions of Higher Education, Hospital, Other Nonprofit Organizations and Commercial Organizations; and certain grants and agreements with States, Local Governments and Indian Tribal Governments; 45 CFR Part 92-Uniform Administrative Requirements for Grants and Cooperative Agreements to State and Local Governments; the HHS Grants Policy Statement (most recent revision); Executive Order 12372, Intergovernmental Review of Federal Programs as implemented through 45 CFR Part 100--Intergovernmental Review of Department of Health and Human Services Programs and Activities.
Regional or Local Office
See Regional Agency Offices. See item 152 Headquarters Office below.
Matthew Avis 12420 Parklawn Drive, Room 3042, Rockville, Maryland 20857 Email: Matthew.Avis@fda.hhs.gov Phone: 301-796-5830
Criteria for Selecting Proposals
All applications will be reviewed for responsiveness by the Grants Management Staff and the Office of Regulatory Affairs (ORA). To be responsive, the application must be submitted in accordance with the requirements of the FOA as published in the NIH Guide or the Federal Register. All responsive applications will be reviewed by an Objective Review committee. Each application will be scored and ranked based on the following criteria 1) availability of adequately trained staff; 2) detailed description of current feed regulatory program; 3) properly detailed budget that is intended to supplement State or Tribal appropriations; 4) accurate count of all feed facilities, etc., in the State or Tribal nation; 5) detailed description of how inspections are to be performed; 6) detailed descriptions of how current, non-inspected facilities will be identified and added to the State's inspection responsibilities: 7) ability to satisfy the reporting requirements; 8) provision of current funding level certification; 9) detailed methodology for program improvement; 10) justification for hiring new staff; and 11) detailed description of the enforcement of violative facilities; under the cooperative agreement all funding will be made by the Commissioner of the Food and Drug Administration or his designee.